These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 438533

  • 1. Levels of exfoliatin antitoxin in pooled human serum globulin.
    Kapral FA.
    J Infect Dis; 1979 Feb; 139(2):209-10. PubMed ID: 438533
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An inhibitor of Staphylococcus aureus exfoliative toxin.
    Al-Sulami AA, Al-Rubiay KK, Affat AM.
    East Mediterr Health J; 2001 Feb; 7(1-2):121-7. PubMed ID: 12596961
    [Abstract] [Full Text] [Related]

  • 6. [Study on staphylococcal exfoliatin (author's transl)].
    Kondo I, Sakurai S.
    Nihon Saikingaku Zasshi; 1979 Mar; 34(2):357-73. PubMed ID: 114684
    [No Abstract] [Full Text] [Related]

  • 7. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice.
    Shibl AM.
    Chemotherapy; 1981 Mar; 27(3):224-7. PubMed ID: 7226975
    [Abstract] [Full Text] [Related]

  • 8. Structure-function analysis of VapB4 antitoxin identifies critical features of a minimal VapC4 toxin-binding module.
    Jin G, Pavelka MS, Butler JS.
    J Bacteriol; 2015 Apr; 197(7):1197-207. PubMed ID: 25622615
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Skin findings of Staphylococcus aureus toxin-mediated infection in relation to toxin encoding genes.
    Courjon J, Hubiche T, Phan A, Tristan A, Bès M, Vandenesch F, Etienne J, Del Giudice P, Gillet Y.
    Pediatr Infect Dis J; 2013 Jul; 32(7):727-30. PubMed ID: 23446443
    [Abstract] [Full Text] [Related]

  • 11. [Change in natural immunity under the effect of cysteine].
    Aver'ianova LA, Speranskaia TA, Fomina VG.
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):142-3. PubMed ID: 211758
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tissue injury by toxins in experimental staphylococcal infections. Effect of polyvalent antitoxin on developing renal lesions.
    Foster EA.
    Am J Pathol; 1967 Nov; 51(5):913-28. PubMed ID: 6054851
    [No Abstract] [Full Text] [Related]

  • 15. Neutralization of Staphylococcus aureus exfoliatin by antibody.
    Miller MM, Kapral FA.
    Infect Immun; 1972 Oct; 6(4):561-3. PubMed ID: 4634954
    [Abstract] [Full Text] [Related]

  • 16. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J, Ritter J.
    Ann Microbiol (Paris); 1980 Oct; 131B(2):175-83. PubMed ID: 6450560
    [Abstract] [Full Text] [Related]

  • 17. [Use of cultured epidermis of human origin for demonstrating the acantholytic action of staphylococcal exfoliatin A].
    Gentilhomme E, Faure M, Arco A, Kanitakis J, Dumaine MH, Marmet D, Binder F, Fleurette J, Thivolet J.
    Pathol Biol (Paris); 1988 Feb; 36(2):121-6. PubMed ID: 3279379
    [Abstract] [Full Text] [Related]

  • 18. Studies on Clostridium oedematiens antitoxin with special attention to anti-lethal and anti-edematous activities.
    Izumi N, Tokumaru Y, Amano T, Niiro M, Kondo H.
    Jpn J Med Sci Biol; 1979 Apr; 32(2):123-4. PubMed ID: 541870
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.